Trial Profile
Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients [EXTENSION OF 700192308]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2013
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Apr 2013 New trial record